Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -17.15% vs 66.78% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -96.48% vs 133.20% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -72.66% vs 176.70% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -9.52% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Jiangsu Aidea Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -17.15% vs 66.78% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 85.76% vs -30.04% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -96.48% vs 133.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 102.83% vs -214.85% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -72.66% vs 176.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 133.64% vs -141.35% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -9.52% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 11.76% vs 21.43% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






